Home › Entities › clinical_trial › Myeloma-Developing Regimens Using Genomics (MyDRUG)

Myeloma-Developing Regimens Using Genomics (MyDRUG)

clinical trial
MedicalStudy clinical_trial Q63595593
Press Enter · cited answer in seconds

Summary

Myeloma-Developing Regimens Using Genomics (MyDRUG) is a clinical trial[1].

Key Facts

  • Myeloma-Developing Regimens Using Genomics (MyDRUG) is in the country of United States[2].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s instance of is recorded as clinical trial[3].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s start time is recorded as +2019-04-01T00:00:00Z[4].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s end time is recorded as +2022-02-10T00:00:00Z[5].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s sponsor is recorded as Multiple Myeloma Research Consortium[6].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s main subject is recorded as multiple myeloma[7].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s number of participants is recorded as {'unit': '1', 'amount': '+228'}[8].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s title is recorded as Myeloma-Developing Regimens Using Genomics (MyDRUG) (Genomics Guided Multi-arm Trial of Targeted Agents Alone or in Combination With a Backbone Regimen)[9].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s short name is recorded as MyDRUG[10].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s ClinicalTrials.gov ID is recorded as NCT03732703[12].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research intervention is recorded as (RS)-cyclophosphamide[13].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research intervention is recorded as dexamethasone acetate[14].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research intervention is recorded as venetoclax[15].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research intervention is recorded as pomalidomide[16].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research intervention is recorded as thalidomide[17].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research intervention is recorded as ixazomib[18].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research intervention is recorded as daratumumab[19].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research intervention is recorded as glycine[20].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s clinical trial phase is recorded as phase I clinical trial[21].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s clinical trial phase is recorded as phase II clinical trial[22].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research site is recorded as Emory University[23].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research site is recorded as Dana–Farber Cancer Institute[24].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research site is recorded as University of Michigan[25].
  • Myeloma-Developing Regimens Using Genomics (MyDRUG)'s research site is recorded as Icahn School of Medicine at Mount Sinai[26].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.
  20. [21] ↑ . wikidata.org.
  21. [22] ↑ . wikidata.org.
  22. [23] ↑ . wikidata.org.
  23. [24] ↑ . wikidata.org.
  24. [25] ↑ . wikidata.org.
  25. [26] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Myeloma-Developing Regimens Using Genomics (MyDRUG). Retrieved May 3, 2026, from https://4ort.xyz/entity/myeloma-developing-regimens-using-genomics-mydrug-
MLA “Myeloma-Developing Regimens Using Genomics (MyDRUG).” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/myeloma-developing-regimens-using-genomics-mydrug-.
BibTeX @misc{4ortxyz_myeloma-developing-regimens-using-genomics-mydrug-_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Myeloma-Developing Regimens Using Genomics (MyDRUG)}}, year = {2026}, url = {https://4ort.xyz/entity/myeloma-developing-regimens-using-genomics-mydrug-}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Myeloma-Developing Regimens Using Genomics (MyDRUG) — https://4ort.xyz/entity/myeloma-developing-regimens-using-genomics-mydrug- (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/myeloma-developing-regimens-using-genomics-mydrug- · Last refreshed: